Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report)’s share price was down 0.9% on Thursday . The stock traded as low as $1.87 and last traded at $1.91. Approximately 78,841 shares traded hands during trading, an increase of 3,542% from the average daily volume of 2,165 shares. The stock had previously closed at $1.93.
Graybug Vision Stock Performance
The business’s 50-day moving average price is $1.81 and its 200-day moving average price is $2.57. The stock has a market cap of $3.01 million, a P/E ratio of -1.11 and a beta of 1.20.
About Graybug Vision
Graybug Vision, Inc, a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema.
Recommended Stories
- Five stocks we like better than Graybug Vision
- 3 Tickers Leading a Meme Stock Revival
- Walmart Stock Alert: Big Price Move Expected Soon
- Stock Analyst Ratings and Canadian Analyst Ratings
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- What is the FTSE 100 index?
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
